" class="no-js "lang="en-US"> Enrique Neumann, Beckman, on Automation Solutions
Thursday, June 08, 2023

Breaking News

Aegis Life Awarded Grant to Develop DNA-encoded Antibodies Against Infectious Diseases New “AI Doctor” Predicts Hospital Readmission and Other Health Outcomes Axol Bioscience Collaborates with StrataStem to Deliver Stem Cell-Based ‘Clinical Trial in a Dish’ for Alzheimer’s Disease MedTech Innovator Asia Pacific Names 24 Startups to Annual Accelerator XNK Therapeutics Appoints Hugo Petit as Chief Financial Officer Bayer Strengthens Gene Therapy Portfolio With Lipid Nanoparticle Technology From Acuitas Therapeutics Abivax Appoints Ida Hatoum as Chief People Officer Eureka Therapeutics Awarded $10.6 Million CIRM Grant to Support Clinical Trial of ARTEMIS® T-Cell Therapy in Pediatric Liver Cancer Kallyope Appoints Franz Humer, Ph.D., as Chair of its Board of Directors BioCentriq® and Kytopen® Expand Partnership to Expedite Impact of Transformative Gene-Editing Technology on Cell Therapy Manufacturing

May 19 2023

Enrique Neumann, Beckman Coulter Diagnostics, on Automation Solutions

In the video, Enrique Neumann, the Field Marketing Manager of Genomics from Beckman Coulter Diagnostics, talks about his company’s automation solutions for laboratories and their range of reagents for genomics.

Neumann highlights the importance of automation in laboratories to improve efficiency, reduce errors, and increase productivity. He explains that Beckman Coulter Diagnostics offers a comprehensive portfolio of automation solutions designed to streamline laboratory workflows and optimize resource utilization.

Neumann also emphasizes Beckman Coulter Diagnostics’ commitment to genomics research and their development of high-quality reagents for genomics applications. He mentions the company’s focus on providing solutions for next-generation sequencing (NGS) workflows, including library preparation and target enrichment.

 

  1. Aegis Life Awarded Grant to Develop DNA-encoded Antibodies Against Infectious Diseases

    Diseases

     Read more
  2. New “AI Doctor” Predicts Hospital Readmission and Other Health Outcomes

    News

     Read more
  3. Axol Bioscience Collaborates with StrataStem to Deliver Stem Cell-Based ‘Clinical Trial in a Dish’ for Alzheimer’s Disease

    Clinical Trials

     Read more
  4. MedTech Innovator Asia Pacific Names 24 Startups to Annual Accelerator

    News

     Read more
  5. XNK Therapeutics Appoints Hugo Petit as Chief Financial Officer

    Appointments

     Read more
More On